Pyrimidine ribonucleoside diphosphate metabolic process

pathway activity — cross-omics
GO:0009193Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Pyrimidine ribonucleoside diphosphate metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the LIVER cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ANKRD13B, PPM1G, and MYC, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine ribonucleoside diphosphate metabolic process activity versus ANKRD13B in LIVER (Pearson r = 0.59).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LIVERANKRD13B →+1.528+0.267.004.00437
SKINPPM1G →+0.651+0.755<.001.00936
OVARYMYC →+1.662+1.088.001.00636
OVARYMLX →+0.557+0.826.001.00736
SKINRUVBL1 →+0.803+0.264.003.00226
LUNG_NSCLC_LUADANXA8 →-2.076-0.156.004.00235
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009193 vs ANKRD13B — LIVER

Per-sample scatter of Pyrimidine ribonucleoside diphosphate metabolic process activity vs ANKRD13B in LIVER.

Explore this scatter interactively →

Exploration